ArticleFrontiers in pediatrics2022

Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China.

Guoqing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.